Pharvaris (PHVS) Fundamental Analysis: Revenue, Earnings & Valuation

4.52 / 10

Netural

Fundamentally, PHVS scores around 4.5/10, reflecting average health. Strong points include a solid interest coverage ratio and favorable revenue‑to‑market‑value metric. Weaknesses are a high current‑liabilities‑to‑total‑liabilities ratio and low PB‑ROE, indicating balance‑sheet pressure.

Analysis Checks(7/10)

Revenue-MV

Value-0.28

Score3/3

Weight98.69%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value78.03

Score2/3

Weight1.36%

1M Return0.13%

Inventory turnover ratio

Value47.95

Score2/3

Weight-11.25%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value98.35

Score0/3

Weight-41.70%

1M Return-4.96%

PB-ROE

Value2.95

Score0/3

Weight33.25%

1M Return2.74%

Long-term debt to working capital ratio (%)

Value0.00

Score2/3

Weight-3.49%

1M Return-0.35%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-11.44%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value92.19

Score2/3

Weight0.55%

1M Return0.05%

Cost of sales ratio (%)

Value70.31

Score2/3

Weight-10.81%

1M Return-1.13%

Asset-MV

Value-0.49

Score0/3

Weight44.85%

1M Return4.00%

Is PHVS undervalued or overvalued?

PHVS scores 4.52/10 on fundamentals and holds a Fair valuation at present. Backed by its -65.19% ROE, 0.00% net margin, -9.06 P/E ratio, 5.87 P/B ratio, and -35.78% earnings growth, these metrics solidify its Netural investment rating.